Reliance Global Group has launched LifeSci Global, a dedicated life sciences platform led by Scott Korman and David Turner, focusing on building and growing biotech companies. The platform's first investment is Innervate Radiopharmaceuticals, which develops PET imaging and therapies for neuroblastoma, with potential expansion into cardiovascular and neurodegenerative diseases. This move aligns with Reliance's strategy of active company-building rather than passive investing, aiming to create long-term value through expert leadership and targeted biotech innovation. LifeSci Global is now evaluating additional opportunities in the life sciences sector.
LEPAS, a mid-to-premium NEV brand under Chery Auto, has introduced the LEPAS L8 PHEV globally, showcasing advanced hybrid technology, smart driving features, and refined design inspired by the agility and resilience of a leopard. The vehicle offers a...
LEPAS, a mid-to-premium NEV brand under Chery Auto, introduced the LEPAS L8 PHEV globally, featuring advanced hybrid technology, elegant design inspired by the agility and strength of a leopard, and smart driving aids. The vehicle offers a leading th...
Chery Auto's NEV brand LEPAS has introduced the LEPAS L8 PHEV globally, combining advanced hybrid technology with intelligent driving features and sophisticated design. Inspired by the precision and resilience of top athletes, the vehicle features a ...
LEPAS, a premium NEV brand under Chery Auto, has introduced the LEPAS L8 PHEV globally, blending elegant design inspired by a leopard's agility with advanced hybrid technology. The vehicle features a highly efficient LEPAS Super Hybrid system with a ...
Chery Auto's LEPAS brand has introduced the L8 PHEV, a mid-to-premium plug-in hybrid vehicle, to the global market. The car features advanced hybrid technology with a 45.79% efficient engine and a 97.6% efficient transmission, delivering ultra-low fu...
